Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline.
Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline.
复制标题
卡麦角林抑制 mTOR 通路并诱导自噬依赖性细胞死亡
DOI:
10.18632/oncotarget.5744
复制
发表时间:
2015-11-17
期刊:
影响因子:
--
通讯作者:
Wu ZB
中科院分区:
文献类型:
--
作者:
Lin SJ;Leng ZG;Guo YH;Cai L;Cai Y;Li N;Shang HB;Le WD;Zhao WG;Wu ZB
Cabergoline (CAB), the first-line drug for treatment of prolactinomas, is effective in suppressing prolactin hypersecretion, reducing tumor size, and restoring gonadal function. However, mechanisms for CAB-mediated tumor shrinkage are largely unknown. Here we report a novel cytotoxic mechanism for CAB. CAB induced formation of autophagosome in rat pituitary tumor MMQ and GH3 cells at the early stage through inhibiting mTOR pathway, resulting in higher conversion rates of LC3-I to LC3-II, GFP-LC3 aggregation, and increased autophagosome formation. Interestingly, CAB treatment augmented lysosome acidification and resulted in impaired proteolytic degradation within autolysosomes. This blocked the autophagic flux, leading to the accumulation of p62 aggregation and undigested autolysosomes. Knockdown of ATG7, ATG5, or Becn1, could significantly rescue the CAB-mediated cell death of MMQ cells (p < 0.05). CAB-induced autophagy and blockade of autophagy flux participated in antitumoral action in vivo. In conclusion, our study provides evidence that CAB concomitantly induces autophagy and inhibits the autophagic flux, leading to autophagy-dependent cell death. These findings elucidate novel mechanisms for CAB action.